Precision Medicine Trailblazer Nuvectis Pharma Secures FDA Orphan Drug Designation for NXP800
The Orphan Drug Designation is more than just a regulatory milestone—it’s a strategic advantage that could dramatically reshape the future of Nuvectis Pharma.